ENO1 and breast cancer: Increased enolase 1 (ENO1) mRNA m6A modification facilitates its binding to the m6A reader YTHDF1 and results in enhanced translation, leading to aerobic glycolysis in human lung adenocarcinoma and breast cancer (Ma et al., 2022; Ou et al., 2021).